Search

Search Constraints

You searched for: Author/Creator Cohen, Jeffrey A.

Search Results

2. Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. (12th September 2017)

3. Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings. (12th September 2017)

4. Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients. (8th November 2016)

5. Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Issue 5 (September 2019)

7. Confirming a Historical Diagnosis of Multiple Sclerosis: Challenges and Recommendations. Issue 3 (June 2022)

8. Consensus Curriculum for Fellowship Training in Multiple Sclerosis and Neuroimmunology. Issue 4 (August 2021)

10. Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers. Issue 4 (August 2018)